Immune biomarkers as predictors of response to mosunetuzumab in previously untreated follicular (FL) and marginal zone lymphoma (MZL). This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
A monocentric real-word experience of CT-IO combination in advanced BTC. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.